Historical Summaries & Sentiment Tracking
cards show the S&P 500's daily move · scroll horizontally → · tracking since Apr 30, 2026
Regime: Risk-On +32
1d · nascent
Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.
Risk-On · supportive
Neutral
Risk-Off · headwind
Stress · fear
Fri
1
7,209
7,229
+0.28%
+1.0
Sat
2
Sun
3
Mon
4
7,230
7,201
-0.40%
-1.1
Tue
5
7,201
7,260
+0.83%
+2.0
Wed
6
7,259
7,366
+1.48%
+2.9
Thu
7
7,365
7,337
-0.38%
-1.1
Fri
8
7,337
7,397
+0.82%
+2.0
Sat
9
Sun
10
Mon
11
7,399
7,413
+0.19%
+0.8
Tue
12
7,413
7,402
-0.15%
-0.6
Wed
13
7,401
7,445
+0.59%
+1.6
Thu
14
7,444
7,502
+0.78%
+1.9
Fri
15
7,501
7,409
-1.23%
-2.3
Sat
16
Sun
17
Mon
18
7,409
7,403
-0.07%
-0.4
Tue
19
7,403
7,355
-0.65%
-1.5
Wed
20
7,354
7,433
+1.08%
+2.3
Thu
21
7,433
7,446
+0.18%
+0.7
Fri
22
7,446
7,474
+0.38%
+1.2
Sat
23
Sun
24
Mon
25
7,446
7,473
+0.37%
+1.2
Tue
26
7,473
7,519
+0.62%
+1.6
Wed
27
7,519
7,521
+0.03%
+0.2
Thu
28
7,520
7,563
+0.57%
+1.6
Fri
29
7,564
7,581
+0.23%
+0.9
Sat
30
Sun
31
Mon
1
7,580
7,600
+0.27%
+0.9
Tue
2
7,600
7,611
+0.14%
+0.6
Wed
3
7,610
7,557
-0.70%
-1.6
Thu
4
7,554
7,585
+0.41%
+1.3
Fri
5
7,580
7,384
-2.59%
-3.7
Sat
6
Sun
7
Mon
8
7,600
7,406
-2.56%
-3.7
Tue
9
7,610
7,387
-2.93%
-4.0
Wed
10
7,554
7,267
-3.80%
-4.7
Thu
11
7,584
7,394
-2.51%
-3.6
Fri
12
7,384
7,431
+0.65%
+1.7
Sat
13
Sun
14
Mon
15
7,406
7,554
+2.01%
+3.5
Tue
16
7,387
7,511
+1.69%
+3.1
Wed
17
7,267
7,420
+2.11%
+3.6
Thu
18
7,394
7,501
+1.44%
+2.8
Fri
19
7,394
7,501
+1.44%
+2.8
Sat
20
Sun
21
Mon
22
7,431
7,473
+0.56%
+1.5
Tue
23
7,554
7,365
-2.50%
-3.6
Wed
24
7,511
7,358
-2.04%
-3.2
Thu
25
7,420
7,357
-0.84%
-1.8
Fri
26
7,501
7,354
-1.95%
-3.1
Sat
27
Sun
28
Mon
29
7,473
7,440
-0.43%
-1.2
Tue
30
7,365
7,499
+1.82%
+3.3
Wed
1
7,358
7,483
+1.70%
+3.2
Thu
2
7,357
7,483
+1.71%
+3.2
Fri
3
7,357
7,483
+1.71%
+3.2
Sat
4
Sun
5
Mon
6
7,354
7,537
+2.49%
+4.1
Tue
7
7,440
7,504
+0.85%
+2.0
Wed
8
7,499
7,483
-0.22%
-0.7
Thu
9
7,483
7,544
+0.81%
+1.9
Fri
10
7,483
7,575
+1.23%
+2.6
Sat
11
Sun
12
Mon
13
7,537
7,515
-0.29%
-0.9
Tue
14
7,504
7,544
+0.53%
+1.5
Wed
15
7,483
7,572
+1.20%
+2.5
Thu
16
7,544
7,534
-0.13%
-0.5
Fri
17
7,575
7,458
-1.55%
-2.6
Sat
18
Sun
19
Mon
20
7,515
7,443
-0.96%
-1.9
Tue
21
7,544
7,509
-0.46%
-1.2
Wed
22
7,572
7,499
-0.97%
-1.9
Thu
23
7,534
7,408
-1.67%
-2.8
Fri
24
7,458
7,412
-0.61%
-1.4
Sat
25
Sun
26
Mon
27
7,443
7,413
-0.40%
-1.1
Tue
28
7,509
7,429
-1.07%
-2.1
Wed
29
7,499
7,316
-2.44%
-3.5
Thu
30
7,408
7,438
+0.40%
+1.2
Fri
31
7,412
7,490
+1.05%
+2.3
Sat
1
Sun
2
Mon
3
7,413
7,601
+2.53%
+4.1
Tue
4
7,429
7,737
+4.14%
+5.6
Wed
5
7,316
7,724
+5.57%
+6.8
Thu
6
7,438
7,710
+3.66%
+5.2
Fri
7
7,490
7,758
+3.58%
+5.1
Sat
8
Sun
9
Mon
10
7,601
7,753
+2.01%
+3.5
Tue
11
7,737
7,728
-0.11%
-0.5
Wed
12
7,724
7,749
+0.32%
+1.1
Thu
13
7,710
7,799
+1.15%
+2.5
Fri
14
7,758
7,786
+0.36%
+1.2
Sat
15
Sun
16
Mon
17
7,753
7,745
-0.10%
-0.5
Tue
18
7,728
7,692
-0.47%
-1.2
Wed
19
7,749
7,708
-0.52%
-1.3
Thu
20
7,799
7,641
-2.02%
-3.1
Fri
21
7,786
7,674
-1.43%
-2.5
Sat
22
Sun
23
Mon
24
Tue
25
Wed
26
Thu
27
Fri
28
Sat
29
Sun
30
Mon
31
Market Recap · August 3, 2026
Strong Up Day
Complacency High- 55% Broad market rally led by NASDAQ (+3.94%), with VIX collapsing 12.9% as complacency took hold and small-cap stocks participated despite trailing the index; SPY +2.53%, Russell 2000 +1.15%, signaling risk appetite across the board.
- 30% Extreme single-stock dispersion drove the day's narrative, with 50 gainers averaging +29.9% (max CYAB +90% on defense contract, AMRC +41% on earnings beat, ATKR +28% on Prysmian acquisition) while 50 losers averaged -20.9%, creating a stock-picker's bonanza that dwarfed macro moves.
- 15% Five debutants and a 4-day ZTG streak underscored the tactical nature of the move; most mega-gainers above +35% lacked news (SZZL, FUSE, GSUN) or drew from micro-cap volatility, suggesting technical/short-squeeze dynamics rather than fundamental repricing across the board.
Market Regime
Risk-On conf: medium macro · prototype+34
VIX15.9 p15
Drawdown-0.1%
Held1d · nascent
SinceAug 3
Top drivers:
VIX percentile ▲
S&P drawdown (60d) ▲
S&P vs 20d avg ▲
Market Indexes
13
S&P 500
7,600.50
+187.32
+2.53%
Dow Jones
53,178.41
+968.33
+1.85%
NASDAQ Composite
25,913.90
+981.82
+3.94%
NASDAQ 100
28,776.80
+737.59
+2.63%
DJ US Total Market
75,233.21
+1,743.66
+2.37%
Russell 1000
4,138.42
+98.86
+2.45%
S&P MidCap 400
3,800.42
+4.64
+0.12%
Russell 2000
2,981.91
+33.87
+1.15%
Russell 2500
1,271.10
+19.67
+1.57%
Russell 3000
4,321.32
+100.95
+2.39%
Nasdaq Financial-100
7,510.88
+105.53
+1.43%
NIFTY 50
24,774.30
+788.95
+3.29%
VIX
15.86
−2.35
-12.91%
Biggest Gainers
50Cyabra announced a major multi-year, six-figure contract with an APAC intelligence agency for AI-powered narrative intelligence services, directly driving the 90% intraday spike as a concrete revenue-generating deal for the defense-tech sector.
The news headline reports a concrete business development win: Cyabra secured a multi-year contract with a government intelligence agency in the Asia-Pacific region, described as six-figure in value and focused on AI-powered threat detection and disinformation defense. This is a material contract announcement that directly expands the company's sovereign and defense footprint in a growing geopolitical segment. For a SPAC-stage or early-revenue defense technology company, a named government contract of this scale typically signals validated product-market fit and recurring revenue visibility, which justifies sharp equity repricing. The timing of the announcement (same trading day) and magnitude of move (90%+) are proportional to a confirmed contract win rather than speculative positioning. No competing negative news appears in the 48-hour window.
A near-89% surge in SZZL on minimal relevant news suggests this is a low-float SPAC or microcap stock experiencing a technical/short squeeze event rather than a fundamental catalyst tied to the single Trasteel industrial news item provided.
The news headline provided concerns Trasteel Holding S.A. announcing an energy efficiency upgrade at a steel facility—a routine operational announcement with no direct connection to Sizzle Acquisition Corp. (SZZL). An 88.98% single-day move on such unrelated news is implausible as a fundamental driver. SZZL is likely a blank-check SPAC or thinly traded microcap with low float and high short interest. These securities are prone to explosive moves driven by technical factors: short squeezes, retail trading waves, options-related gamma effects, or rumored merger/deal announcements circulating on social media. The magnitude of the move suggests algorithmic or momentum-driven trading rather than news digestion. Without a headline directly naming SZZL or announcing a merger, SPAC warrant redemption, or business combination, the true catalyst remains hidden.
No news headlines were found in the last 48 hours, so the 63% jump on FUSE likely reflects either a delayed market reaction to an earlier announcement, a rumor or technical event not yet captured in major headlines, or typical SPAC volatility around business combination developments.
Fusion Acquisition Corp is a blank-check company, and SPACs are prone to sharp, sudden moves driven by rumors of merger targets, shareholder votes, deal announcements, or business combination closings that may circulate before formal press releases appear in major news feeds. The absence of headlines in the RSS snapshot does not rule out real catalysts; it may indicate the move preceded index processing, occurred via corporate filings or social media, or reflects a delayed reaction to news from earlier periods. Without a specific announcement to point to, the jump could also reflect technical factors such as short covering, options expiration effects, or redemption-related dynamics common in SPAC structures. The magnitude (63%) is consistent with SPAC-related events rather than broad market moves.
No news headlines were found in the last 48 hours, so the 44.51% gain cannot be directly attributed to a reported event. The move likely reflects technical or sentiment-driven trading in a micro-cap stock.
Golden Sun Education Group is a micro-cap stock trading at $0.55 with no recent news coverage available. Stocks at this price level and market cap tier are typically subject to outsized price swings driven by factors other than fundamental news, including technical bounces from support levels, retail trading activity, short covering, or unconfirmed rumors on social media. Without access to intraday volume data, options activity, short interest changes, or social media mentions, it is not possible to identify which mechanism drove today's gain. The absence of news does not mean nothing happened; it simply means no material news was released through major financial wire services in the period covered.
No news headlines were found in the last 48 hours, so the 43.83% jump in ATXI stock cannot be directly attributed to any reported event. The move likely reflects either a technical rebound, delayed market reaction to earlier news, or speculative interest in this micro-cap biotech name.
Avenue Therapeutics is a small-cap biotech company, and the absence of breaking news in the provided headline feed does not necessarily mean no catalyst occurred. The stock could be rebounding from oversold technical conditions, responding to news published before the 48-hour window, or experiencing increased speculative trading common in sub-dollar biotech stocks. Biotech stocks in this price range are often sensitive to clinical trial updates, regulatory submissions, partnership announcements, or shifts in sentiment around pipeline assets. Without access to actual press releases or company filings from the relevant period, the specific driver remains unknown. The move ranks in the top 5 gainers, suggesting material interest rather than random noise, but that alone does not identify the cause.
No news headlines were found in the last 48 hours, so the 43% gain in Diana Shipping's warrant cannot be directly attributed to a specific announcement, leaving the cause uncertain.
The absence of recent news headlines makes it difficult to identify a concrete catalyst for the 43.43% jump in DSX.WT. However, warrants on shipping stocks can be sensitive to several factors: shifts in underlying shipping rates or market sentiment, changes in the parent company Diana Shipping's equity price, volatility spikes that increase warrant value, or technical trading activity in a thinly traded security. Warrants are leveraged instruments, so even modest percentage moves in the underlying stock or in implied volatility can produce outsized percentage swings. Without an earnings report, contract announcement, debt restructuring news, or operational update visible in the headlines, the move may reflect intraday technical buying, updated market expectations about shipping demand, or information not yet surfaced in the RSS feed provided.
Ameresco beat Q2 revenue expectations with $515.5 million in sales, up 9.1% year-over-year, triggering a 41.82% single-day gain after the earnings announcement on August 3rd.
Ameresco reported second quarter 2026 financial results on August 3rd that surpassed Wall Street consensus estimates. The company delivered $515.5 million in revenue, representing 9.1% year-over-year growth. The earnings beat alone drove an initial 20.9% intraday move according to the first news headline, and the stock continued climbing to close up 41.82%, suggesting sustained buying momentum and possibly positive forward guidance or analyst revisions following the announcement. The company also provided full-year revenue guidance, though the exact figures are not detailed in the snippets provided. For an energy infrastructure and renewable energy company, beating top-line expectations and showing operational growth can trigger substantial re-rating, especially if the market had been skeptical or if management raised annual guidance materially.
No news headlines were found in the last 48 hours for ZBAO, so the 40% gain cannot be attributed to a disclosed catalyst. The jump likely reflects technical trading, short covering, or undisclosed company developments.
ZBAO experienced a significant single-day surge to rank eighth among NASDAQ gainers, yet zero news items appear in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect is noteworthy. For a micro-cap stock trading at $0.25, such moves often reflect low liquidity amplifying modest volume shifts, short-squeeze dynamics if the stock carries elevated short interest, or delayed dissemination of material news that has not yet been indexed by major financial news aggregators. It is also possible that relevant news was issued through direct company channels or lower-circulation sources not captured in standard RSS feeds. Without access to real-time news wires, SEC filings timestamped on or immediately before August 3, or short interest data, the proximate cause remains unidentified.
Reliance Global Group announced a letter of intent to sell its Altruis Benefit Consulting subsidiary for $11 million in cash, which would eliminate all term debt and generate approximately $7.6 million in incremental cash, triggering a 40% intraday rally.
On August 3, 2026, Reliance Global Group signed a non-binding LOI to divest Altruis Benefit Consulting for $11 million cash. The transaction is characterized as all-cash and non-dilutive, with proceeds expected to retire 100% of the company's term debt while leaving approximately $7.6 million of net cash after debt retirement. For a micro-cap stock trading at $2.60, debt elimination and cash generation represent material balance sheet improvements that reduce financial risk and provide liquidity for continued operations or growth investments. The announcement came during market hours on August 3, and the 40% same-day gain reflects investor enthusiasm for the deleveraging event. Note that the LOI is non-binding, so execution risk remains, but the announcement itself appears to have been the catalyst.
ParaZero announced receipt of an initial order from a Tier-1 European defense manufacturer for its autonomous Counter-UAS platform using net-based interception technology, which likely catalyzed the 39.35% single-day gain on the micro-cap stock.
The news headline describes a concrete commercial win: ParaZero has received an initial order from a major European defense contractor to integrate its physical interception technology into an autonomous counter-unmanned aircraft system platform. For a small-cap defense technology company trading at $0.52, a named order from a Tier-1 manufacturer represents material validation of product-market fit and revenue opportunity. The stock's ranking as the 10 biggest gainer on August 3rd, combined with the same-day announcement, suggests the market interpreted this as meaningful progress toward commercialization in the growing counter-UAS sector. Micro-cap stocks typically exhibit outsized percentage moves on contracted orders because the revenue base is small relative to enterprise value. The headline provides specific details (named customer tier, technology type, system integration) that establish credibility rather than mere speculation.
Gen Digital launched the Fearless Planet Index on August 3, which may have sparked investor optimism about the company's digital freedom positioning, though the specific market impact of this announcement on the CVR is unclear from available information.
The only headline provided is Gen Digital's launch of the Fearless Planet Index on the same day as the 37% jump in GENVR (the contingent value rights tied to Gen Digital). The announcement describes a new index related to the company's "Digital Freedom" mission across its Norton, Avast, LifeLock, and MoneyLion brands. However, the headline provides no details about the index's significance, market reception, or commercial impact. A 37% single-day move in a CVR is substantial but CVRs are structurally volatile securities with small trading volumes and can be sensitive to parent company sentiment shifts or technical factors. Without clarity on whether this index announcement was market-moving or merely coincidental timing, and without understanding the specific terms of the CVR (trigger events, expiration, etc.), the connection between the news and the price action remains speculative.
No news headlines were found in the last 48 hours, so the 36.82% surge in ULH cannot be directly attributed to a disclosed event. The move likely reflects technical trading, a delayed news release, or short-covering activity.
Universal Logistics Holdings experienced a sharp single-day rally of nearly 37% with no corresponding news coverage detected in the provided sources. This disconnect between magnitude and headline availability suggests several possible explanations. A logistics and transportation company like ULH could have responded to positive developments in freight markets, carrier pricing, or company-specific contract wins that have not yet been widely syndicated through major financial feeds. Alternatively, the move could reflect technical factors such as short-covering, options-related hedging dynamics, or a broader rally in the transportation sector that preceded or accompanied this individual stock's jump. Without corroborating news, it is impossible to distinguish between a delayed announcement, insider activity, or pure market mechanics.
No news headlines are available in the last 48 hours, so the 36.58% gain cannot be directly attributed to a disclosed catalyst. The move likely reflects technical trading, a delayed market reaction, or undisclosed rumors in a micro-cap stock.
IPW is a micro-cap stock trading at $0.53 with no recent news coverage in the Yahoo Finance RSS feed. Stocks at this price point and market capitalization tier are often subject to outsized moves driven by factors other than fundamental news: technical rebounds off support levels, short covering, retail speculation, or thinly-traded volume amplification. Without access to real-time trading data, social media sentiment, or insider activity, it is impossible to determine whether this move reflects a legitimate fundamental catalyst that has not yet reached major news outlets, simple mean-reversion buying, or speculative positioning. The absence of news is itself noteworthy but not conclusive.
Voyager Technologies announced record second quarter 2026 financial results on August 3, which likely drove the 34% intraday surge as investors reacted to better-than-expected earnings.
The company released Q2 2026 results on the same day as the stock's sharp 34% jump, making a direct causal link highly plausible. The headline explicitly states "record" results, which signals earnings that exceeded expectations or prior performance. However, the RSS feed excerpt does not provide specific metrics—revenue, EPS, margin data, or forward guidance—that would let us confirm the magnitude of the beat or identify which metrics drove the rally. The timing alignment between the announcement and the move is strong circumstantial evidence, but without the actual financial figures or management commentary, we cannot rule out that the stock may have also benefited from short covering, sector rotation, or a broader market catalyst that coincided with the earnings release.
No news headlines were found in the last 48 hours, so the 30.41% gain likely reflects a technical rebound, retail momentum, or undisclosed corporate development in this micro-cap stock.
Stardust Power Inc. is trading at $0.69 and experienced a significant single-day gain of over 30%, placing it in the top 15 gainers on NASDAQ. However, no news headlines appear in the Yahoo Finance RSS feed for the past 48 hours that would directly explain this move. For micro-cap stocks trading at sub-dollar prices, price action is often driven by technical factors such as short covering, algorithmic triggers at round price levels, or thin-liquidity reversals rather than fundamental news. It is also possible that a corporate announcement or press release was issued but has not yet been picked up by major financial news aggregators, or that retail investor attention via social media or message boards catalyzed demand. Without access to the company's investor relations announcements or trading volume data, any explanation remains speculative.
Pulmonx received a Zacks Rank upgrade to 2 (Buy) on August 3rd based on improved earnings prospects, likely driving the 30% single-day gain as investors reacted to the positive analyst revision.
The headline confirms a Zacks Rank upgrade to Buy on the same day as the 30% gain, which provides direct timing alignment. The upgrade cites growing optimism about earnings prospects as the rationale. This is a straightforward analyst endorsement that can influence retail and algorithmic trading, particularly in smaller-cap healthcare stocks like Pulmonx where analyst sentiment often carries outsized weight. However, the headline does not specify what triggered the upgrade itself—whether it was new clinical data, operational milestones, revised guidance, or simply reassessment of existing information. The upgrade timing coinciding exactly with the stock's top-16 gainer ranking suggests the market responded promptly to the analyst action, but we lack visibility into the underlying catalyst that prompted Zacks to upgrade in the first place.
The news provided discusses an NYSE/Intercontinental Exchange acquisition of MarketAxess but contains no information about IMC Rare Earths Ltd, making the cause of this 29% jump unclear from available headlines.
The only headline supplied is about the NYSE acquiring MarketAxess, which is unrelated to IMC Rare Earths Ltd, a rare earth elements company. This suggests either a data collection gap or that the real catalyst occurred outside the provided news window. Rare earth stocks typically respond to several categories of events: supply chain developments, geopolitical shifts affecting mining or processing, earnings surprises, changes in demand from defense or renewable energy sectors, or shifts in Chinese export policy. The 29% single-day jump is substantial and suggests either a material company-specific announcement, sector-wide positive news (such as U.S. rare earths policy support or new contracts), or technical/momentum-driven movement. Without aligned headlines, determining the actual trigger requires additional reporting.
No news headlines were reported in the last 48 hours for IPDN, so the 29.4% gain likely stems from technical trading activity, retail momentum, or an untracked announcement outside the major news feeds.
The absence of any recent news headlines in the Yahoo Finance RSS feed during the snapshot period makes it impossible to attribute the price jump to a specific corporate event such as earnings, acquisitions, guidance changes, or regulatory developments. IPDN is a micro-cap stock trading at $0.43, which typically exhibits higher volatility and is more susceptible to technical factors including short covering, momentum trading, and low-volume price swings. The stock's low price and apparent liquidity characteristics may also make it sensitive to retail trading interest or social media-driven activity. It is also possible that a material announcement was made but has not yet propagated through the major news feeds tracked by Yahoo Finance, though we cannot confirm this based on the information provided.
No news headlines were found in the last 48 hours, so the 29% jump in CNCK shares likely stems from technical trading, a delayed market reaction to a prior announcement, or retail interest in a crypto-related asset.
Coincheck Group is a Japanese cryptocurrency exchange operator whose shares trade on NASDAQ. The stock surged 29% on August 3, 2026, but no news headlines appeared in the prior 48 hours. This disconnect suggests either that a catalyst exists but was not captured by the RSS feeds monitored, the market is reacting to something announced more than 48 hours ago, or the move is driven by technical factors such as short covering, options activity, or renewed retail interest in the crypto sector. Cryptocurrency-related equities are historically sensitive to sentiment swings in underlying digital asset markets, regulatory announcements affecting the broader sector, and momentum-driven trading. Without a specific headline pinpointing the catalyst, any explanation remains speculative.
Atkore surged 28% on August 3rd after announcing a definitive acquisition agreement by Italian cable company Prysmian for $3.8 billion in an all-cash deal, combined with a strong Q2 earnings beat that exceeded analyst estimates on both revenue and profit.
The stock's sharp rally was driven by two simultaneous positive catalysts announced on the morning of August 3rd. First, Atkore reported fiscal third-quarter results that significantly beat consensus expectations, with earnings surprising 30.61% above estimates and revenue 4.98% above forecasts, supported by Q2 revenue growth of 8.1% year-on-year to $794.8 million and non-GAAP EPS of $1.92, which was 24.9% above consensus. Second and more significantly, the company announced a definitive merger agreement with Prysmian SpA at approximately $95 per share, representing a 30% premium over the previous closing price and valuing the transaction at $3.8 billion in all cash. The combination of a strong operational beat and a tangible acquisition at a meaningful premium explains the substantial single-day gain, as shareholders received both validation of business health and immediate deal certainty.
No news headlines were reported in the last 48 hours for HEPA, so the 25% jump on August 3rd cannot be directly attributed to a disclosed catalyst. The move likely reflects either technical trading activity, delayed news pickup, or market rumors not yet captured in major financial media.
Despite the substantial 25% single-day gain that ranked HEPA as the 21st biggest gainer on NASDAQ, no corresponding news headlines appeared in the Yahoo Finance RSS feed within the prior 48 hours. This disconnect suggests either a delayed news dissemination lag, a technical or algorithmic trading event, or unconfirmed market chatter. For a micro-cap pharmaceutical stock like HEPA trading at $0.06, price moves of this magnitude can occur on modest volume driven by retail interest, short covering, or speculative positioning rather than fundamental catalyst. It is also possible that a significant announcement (clinical trial results, partnership, financing update, or regulatory filing) occurred but had not yet been indexed or picked up by the RSS feed at the time of this analysis.
JELD-WEN reported better-than-expected Q2 2026 earnings and updated full-year guidance, triggering a 25% jump as the market rewarded the earnings beat and forward-looking signal.
JELD-WEN released Q2 2026 results on August 3rd that beat expectations despite flat year-over-year revenue of $817.8 million. The headline explicitly states the stock jumped 19.3% on the earnings announcement, with the remaining gains likely flowing from the updated full-year revenue guidance of $3.15 billion. While the revenue line itself was not growing, the company's ability to beat analyst expectations on profitability or margin metrics, combined with a maintained or raised forward guidance, typically signals management confidence and operational discipline. For a building products manufacturer, this kind of earnings surprise often reflects either operational efficiency gains, favorable pricing power, or better-than-expected project wins. The 25% one-day move ranks this among the day's largest gainers, consistent with the magnitude of surprise earnings typically deliver.
No news headlines were published in the last 48 hours for CHARR, so the 24% gain likely reflects either technical trading in a low-priced SPAC rights vehicle or a delayed market reaction to an untracked announcement or merger development.
Charlton Aria Acquisition Corporation is a Special Purpose Acquisition Company (SPAC) rights unit, a category of security that tends to be thinly traded with high volatility and low absolute prices. The absence of any Yahoo Finance headlines in the last 48 hours means we cannot point to a specific corporate catalyst such as a merger announcement, business combination update, or shareholder vote result. However, SPAC rights units are sensitive to developments in the parent SPAC's target acquisition negotiations, redemption activity, or deal completion timelines. The 24% move could reflect intraday technical momentum in a low-liquidity security, institutional accumulation ahead of a known deadline, or a market reaction to news that was published outside the RSS feed being monitored. Without access to broader newswire services or the company's investor relations channel, a specific cause cannot be identified from the evidence provided.
Adagio Medical announced it treated its first patient with its next-generation ULTA cryoablation system on August 3, 2026, a product advancement that likely drove the 24% gain as investors reacted positively to clinical progress in the company's core cardiac ablation technology.
The headline documents a clinical milestone: Adagio Medical successfully treated the first patient using its faster, single-freeze next-generation ULTA System for cardiac arrhythmia ablation. This represents tangible progress on a key product innovation and signals advancement toward commercialization of an improved ablation platform. For a small-cap medtech company like Adagio, achieving first-patient treatment with a next-generation system is typically a positive catalyst, as it reduces technical risk, validates the design, and moves the product closer to revenue generation. The stock's 24% same-day jump aligns with typical investor sentiment around clinical milestones in the cardiac device space, where product differentiation and technological superiority directly drive commercial potential and market share opportunity.
No news headlines were available in the last 48 hours, so the 23.87% gain cannot be directly attributed to a specific announced event. The move likely reflects technical trading, delayed news pickup, or market rumors common to small-cap stocks.
N2OFF, Inc. is a micro-cap stock trading on NASDAQ at $2.06 with a strong single-day gain ranking it 25th among daily movers. However, no news headlines from the prior 48 hours are available to explain the move. For small-cap stocks at this price level, significant single-day rallies often stem from a few categories: technical or short-covering activity, delayed press-release pickups by financial aggregators, unconfirmed social media discussion or message-board momentum, or incoming news that has not yet propagated to major RSS feeds. Without access to company press releases, SEC filings, or other primary sources beyond the Yahoo Finance RSS feed provided, it is not possible to identify the specific catalyst. The lack of news availability itself suggests either minimal institutional coverage or a delay in information distribution typical of low-liquidity securities.
ZTG surged 23.46% on August 3, 2026, but no news headlines were available in the prior 48 hours to identify a specific catalyst, leaving the cause unclear.
No recent news headlines were found in the Yahoo Finance RSS feed for the 48 hours preceding this 23.46% jump, making it impossible to attribute the move to a discrete event like earnings, regulatory approval, guidance revision, or partnership announcement. For a NASDAQ-listed company, such a large single-day gain without accompanying public disclosure could stem from several categories of cause: technical factors such as short covering or algorithmic trading, delayed reporting of an earlier announcement, a social media-driven retail trading surge, insider trading activity preceding a future announcement, or sector-wide momentum. Without additional information about ZTG's market cap, float, ownership concentration, or recent price history, it is not possible to determine whether this is a small-cap illiquidity phenomenon, a squeeze event, or genuine fundamental news that has not yet surfaced in major financial feeds.
No news headlines were available in the last 48 hours to explain the 22.89% gain in this warrant, so the driver remains unclear; typical causes for warrant spikes include movement in the underlying stock, volatility expansion, or technical factors.
Bain Capital GSS Investment Corp. WT is a warrant that derives its value from the underlying common stock and broader market conditions. Without any news headlines in the last two days, we cannot identify a specific corporate catalyst such as earnings, merger news, or guidance changes. Warrants are particularly sensitive to moves in their underlying security and to implied volatility shifts. The jump could reflect a rally in BCSS common shares themselves, increased interest in the SPAC or its investment thesis, technical buying following a prior sell-off, or simply low trading volume amplifying normal price swings on small-cap warrants. Without access to concurrent moves in BCSS common or broader market context, any specific cause is speculative.
T1 Energy (ticker TE) announced a major 641MW solar module supply agreement with Clearway Energy on August 3, which likely drove the 22.57% intraday gain as investors responded to the strategic partnership and revenue visibility.
The two headlines published within 23 minutes of each other on August 3 describe the same supply agreement between T1 Energy and Clearway Energy Group. T1 will supply 641 megawatts of solar modules manufactured with domestically produced solar cells, and Clearway is described as securing traceable, high-performance modules through this strategic offtake deal. For a solar equipment manufacturer, a major domestic supply contract of this scale provides concrete revenue visibility, demonstrates market demand for domestically sourced cells, and validates the company's manufacturing capabilities. The timing of the announcement with the intraday 22.57% jump suggests market participants reacted positively to the deal's commercial significance. The domestic sourcing angle may also resonate with investors focused on supply chain resilience and potential policy tailwinds for U.S. solar manufacturing.
No news headlines were found in the last 48 hours, so the 22.32% gain likely stems from technical factors, delayed coverage of an earlier announcement, or market rumors rather than a fresh public disclosure.
CalAmp experienced a strong single-day rally to the 29 spot among gainers, yet zero news items appeared in the Yahoo Finance RSS feed over the past two days. This disconnect suggests either that the catalyst occurred earlier and is being revisited, that the move is driven by technical factors such as short covering or algorithmic triggers, or that information circulated through channels not captured in the headline feed. CalAmp operates in IoT and fleet management, sectors historically sensitive to quarterly earnings surprises, partnership announcements, or strategic pivots. Without access to earnings calendars, insider activity, or broader market sentiment shifts on the snapshot date, attributing the move to a specific business catalyst remains speculative.
No news headlines were found in the last 48 hours for MRDN, so the cause of the 21.76% surge cannot be directly identified from available reporting. The move likely reflects either delayed news dissemination, technical trading, or a market-moving event not yet captured by the news feed.
Golden Matrix Group is a gaming and digital entertainment company, and a 21.76% single-day gain without accompanying news headlines in the RSS feed is notable. This could reflect several non-mutually-exclusive scenarios: first, news may have been published but not yet indexed by the RSS feed used here, creating a lag between the actual event and this snapshot; second, the stock may have experienced technical momentum or short-covering if it has a substantial short float; third, there could be an unannounced corporate development such as a partnership, licensing deal, or strategic acquisition that the market is responding to but that has not yet reached mainstream financial news outlets. Gaming and digital entertainment stocks can be volatile and sometimes react to social media momentum or industry-specific catalysts before broad press coverage. Without access to real-time news, SEC filings, or company press releases directly, the specific trigger remains unknown.
NOTE surged 21.67% on news that FiscalNote will report Q2 2026 earnings and host a conference call on August 10, 2026, likely driven by anticipation ahead of the earnings announcement.
The only headline provided is a scheduled earnings announcement for August 10, 2026. The stock jumped on the day of that announcement, which suggests investors may be positioning ahead of the earnings call or reacting to positive sentiment around the company's upcoming disclosure. However, the headline itself contains no financial guidance, no preliminary results, and no qualitative commentary that would explain the specific magnitude of the gain. This is a routine quarterly earnings notification rather than a surprise or material update. The 21.67% move is notable for what amounts to a calendar announcement, which could indicate either broader market interest in FiscalNote's AI-driven policy intelligence business, short covering, or speculative positioning ahead of the actual results on August 10.
Vision Marine announced progress on its E-Motion electric marine engine integration program with STERK Yachts, likely triggering investor optimism about commercialization momentum and partnerships in the recreational boating market.
The company released news on 2026-08-03 describing advancement of its European integration program for its E-Motion propulsion technology, specifically mentioning plans to begin integration and on-water evaluation with STERK Yachts. This represents tangible progress toward commercial deployment rather than purely developmental activity. For a small-cap marine technology company, concrete partnership announcements and integration milestones are typically significant catalysts because they reduce perceived execution risk and validate market demand. The 21.4% single-day gain is consistent with investor enthusiasm for proof of commercial traction. However, the headline provided is incomplete (text cuts off mid-sentence), so the full scope of the announcement cannot be assessed. No financial metrics, timeline specifics, or commercial terms are visible in the excerpt.
No news headlines were found in the last 48 hours, so the 21.36% gain on August 3rd likely reflects technical trading activity, short covering, or undisclosed company developments in a thinly traded microcap stock.
China SXT Pharmaceuticals is a microcap pharmaceutical stock trading at $0.08 per share on NASDAQ, and the absence of any news in the past two days makes it impossible to attribute the jump to a specific corporate announcement or market event. Stocks in this price range and liquidity profile are susceptible to multiple non-news-driven catalysts: technical bounces after oversold conditions, short squeeze activity if significant short interest exists, retail trading volume spikes driven by social media or trading forums, or delayed reporting of company news that has not yet reached mainstream financial feeds. Small pharmaceutical companies can also benefit from general sector momentum or from clinical trial results posted directly to company websites before formal press releases appear. Without access to real-time trading data, insider transactions, or social media activity, the precise trigger remains unknown.
No news headlines appeared in the last 48 hours for SLBT, so the 21.15% gain likely reflects either delayed market reaction to an earlier announcement, technical trading activity, or a company-specific catalyst not yet captured in the RSS feed.
The absence of recent headlines in the last 48 hours makes it difficult to pinpoint a specific catalyst for SLBT's sharp 21.15% gain on August 3, 2026. Without access to the company's operations, pipeline, or financial standing, plausible drivers could include a delayed market reaction to an earnings release or regulatory approval that may have occurred just outside the 48-hour window, short-covering activity in a thinly traded security, or an announcement via the company's investor relations channels that has not yet been indexed by the Yahoo Finance RSS feed. Microcap NASDAQ stocks in the $3 range can also be subject to momentum trading or options-related moves that amplify intraday swings. Without substantive news evidence, attributing the move to any one cause would be speculation rather than analysis.
No news headlines were found in the last 48 hours for CBRG, so the 20.97% jump cannot be attributed to a specific announced catalyst; the move likely reflects either a delayed market reaction, technical trading, or untracked developments.
Chain Bridge I is a SPAC listed on NASDAQ, and no headlines appeared in the Yahoo Finance RSS feed in the 48 hours preceding this 20.97% gain. Without access to the underlying news, we cannot confirm whether the move stems from a merger announcement, business combination closing, regulatory approval, or other corporate event that might drive such a jump. SPACs are particularly sensitive to announcements regarding their proposed mergers or de-SPAC transactions, changes in deal timelines, or shareholder voting outcomes. The absence of captured headlines does not rule out that such an event occurred; it may reflect gaps in the RSS feed coverage or a late announcement that did not yet propagate widely. Alternatively, the move could reflect technical momentum, options activity, or delayed market digestion of earlier news.
No news headlines were published in the last 48 hours for Luminex, so the +20.82% gain cannot be tied to a specific announced catalyst. The move likely reflects technical factors, delayed news dissemination, or market sentiment unrelated to public disclosures.
The absence of any news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to earnings, FDA decisions, contract wins, guidance changes, or M&A activity as the cause of this substantial 20.82% rally. Luminex is a diagnostics and life sciences tools company, which typically responds to clinical trial results, regulatory approvals, partnership announcements, or quarterly results. Given the magnitude of the gain and its rank as the 36th biggest gainer, it is possible that material news exists but has not yet been indexed by the source used, that the move reflects short covering or technical momentum, or that the catalyst appeared in a form not captured by standard financial news feeds. Without headline evidence, attributing the move to any specific event would be speculation.
No news headlines were found in the last 48 hours, so the 20.68% gain on AIXC likely reflects technical trading, retail interest in a low-priced crypto-related stock, or an off-exchange announcement not yet indexed by Yahoo Finance.
The absence of recent news headlines makes it impossible to pinpoint a specific corporate catalyst for AIXC's jump to 37 biggest gainer. However, this stock trades at $0.79 and carries a crypto-related name, which typically makes it susceptible to momentum-driven moves, retail trading bursts, and volatility unmoored from fundamentals. Possible explanations include a social media catalyst, technical breakout, sector rotation into crypto holdings, or a delayed press release not yet captured in the news feed. Without access to intraday chat activity, options flow, or company filings released within the snapshot window, we cannot confidently attribute the move to a specific event. The price action alone—a ~21% single-day gain—is consistent with both speculative accumulation and genuine news, but the evidence simply does not exist in the provided headlines.
CoreWeave surged 20.5% after positive sentiment on AI infrastructure demand, Cathie Wood's $26M stake increase, a new Leidos federal partnership, and analyst commentary highlighting the stock's deep NVIDIA integration and the persistent AI compute shortage despite Meta's supply moves.
Multiple reinforcing catalysts emerged on August 3rd. The headline "What's Going On With CoreWeave Stock Monday" explicitly attributes the jump to AI infrastructure spending momentum. Separately, news broke that Cathie Wood added approximately $26 million to CoreWeave positions across Ark funds, signaling institutional conviction. The Leidos partnership announcement from August 2nd provides a tangible enterprise contract with federal agencies. Morningstar's commentary on Meta's AI capacity sales actually reinforced rather than threatened the bull case, arguing the move confirms structural supply-demand imbalance favoring providers like CoreWeave. A geopolitical risk-off moment reportedly triggered a morning "flip" that benefited AI cloud stocks. The stock's $100 billion revenue backlog relative to near-52-week-low pricing was cited as a potential opportunity, suggesting valuation support. These factors collectively created a momentum day for the stock.
AIRJ surged 20.36% on August 3, 2026, but the available headline explicitly states there was apparently no good news or event that day to justify the move, leaving the specific catalyst unknown.
The Yahoo Finance article titled "Why Did AirJoule Stock Pop Today?" directly acknowledges that AirJoule stock rose substantially but found no identifiable newsworthy catalyst for the gain on that specific date. The article notes the stock "has potential" but suggests the jump lacked fundamental justification from announced events. For a SPAC or blank-check company like Power & Digital Infrastructure Acquisition II Corp., typical catalysts include merger agreement announcements, business combination updates, insider purchases, short covering, or technical momentum in thinly traded securities. Without concrete news provided, the 20% move falls into the category of price action without clear fundamental drivers.
No news headlines were found in the last 48 hours, so the 20% intraday gain cannot be attributed to a specific announced catalyst. The move is likely driven by technical factors, warrant-specific dynamics, or unannounced developments.
NWAX.WT is a warrant security linked to New America Acquisition I Corp., a SPAC. No recent news appears in the Yahoo Finance RSS feed, which means any catalyst behind today's 20% jump is not documented in mainstream headlines. Warrant securities are structurally leveraged instruments that amplify price moves relative to their underlying common stock and can exhibit outsized daily volatility. Without news, the gain could reflect several possibilities: a technical rebound after prior weakness, arbitrage activity between warrant and common units, rumors or investor chatter not yet captured in formal announcements, or delayed market reaction to an undisclosed corporate event. SPACs also carry inherent volatility around merger completion timelines and shareholder votes, though no such event is mentioned here.
No news headlines were found in the last 48 hours for OptimumBank Holdings, so the nearly 20% gain likely reflects a technical bounce, delayed market reaction to older news, or untracked catalyst.
OptimumBank Holdings jumped 19.97% on August 3, 2026, ranking 41st among daily gainers, but the Yahoo Finance RSS feed returned no relevant headlines in the preceding 48 hours. This absence of contemporaneous news coverage makes it difficult to pinpoint a specific catalyst. For a small-cap financial services stock like OptimumBank, typical catalysts that can drive sharp single-day moves include quarterly earnings surprises, dividend announcements, M&A rumors, regulatory approval, changes in lending guidance, or shifts in interest rate expectations. It is also possible the move reflects a technical rebound after prior weakness, short covering, or an announcement that spread through alternative channels before reaching major news feeds. Without corroborating headlines, these remain educated guesses rather than confirmed drivers.
No news headlines were found in the last 48 hours, so the cause of the 19.75% gain cannot be directly attributed to a specific announcement or event. The move likely stems from technical factors, delayed news, or market rumors not yet captured in the available feeds.
VYNE Therapeutics is a small-cap biopharmaceutical company, and without any recent headlines in the Yahoo Finance RSS feed, the driver of this significant 19.75% intraday gain remains unclear from the provided evidence. For a biotech stock of this size, typical catalysts include clinical trial results, FDA approval or rejection decisions, partnership announcements, licensing deals, or strategic shifts. It is also possible that news broke on other channels before appearing in RSS feeds, or that the move reflects technical momentum following accumulation by larger holders. Short squeeze dynamics are another consideration for smaller-cap stocks with significant short interest, though this cannot be confirmed without data on short positions and volume. Without a specific news anchor, attribution to any particular cause is speculative.
No news headlines were found in the last 48 hours, so the 19.39% gain on LTCH likely reflects technical trading, a delayed announcement, or a rumor not yet captured in major financial media.
Latch is a small-cap security trading at $0.18 with no recent news available to explain a nearly 20 percent single-day move. At this price point and market cap, the stock is susceptible to retail trading flows, short covering, or thin-liquidity rallies that can move sharply on minimal volume. Without identifiable fundamental catalysts in the provided headlines, the move could stem from several sources: a press release issued after market hours or not yet indexed by the RSS feed, short-squeeze dynamics common in low-float stocks, technical reversal trading off support levels, or social media momentum. Mid-cap and micro-cap security moves of this magnitude are frequently driven by factors other than broad market news, making attribution difficult without supplementary market data or order flow information.
No news headlines were found in the last 48 hours, so the 19.27% gain likely reflects either delayed market reaction to an earlier announcement, technical trading, or an untracked catalyst. BioAge is a clinical-stage biotech company where such moves often follow clinical trial results or funding …
Despite the substantial single-day gain ranking BIOA as the 44th biggest mover on NASDAQ, no recent news headlines are available to explain the jump. For early-stage biotech firms like BioAge Labs, which focuses on aging and longevity research, significant price moves typically correlate with clinical trial outcomes, regulatory developments, partnership announcements, or funding events. The absence of tracked headlines suggests either that the catalyst occurred outside the measured 48-hour window, was not yet picked up by the RSS feed at the time of this report, or the move was driven by technical factors such as short covering, options expiration activity, or retail trading patterns rather than fundamental news.
No news headlines appeared in the last 48 hours for AXTI, so the 19.15% jump on August 3rd cannot be directly attributed to a publicly reported event. The move likely reflects technical trading, delayed news processing, or undisclosed market activity.
AXT Inc (AXTI) posted a strong single-day gain of roughly 19% while ranking in the top 50 gainers, yet no corresponding news articles appear in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect is notable and suggests several possibilities. First, the catalyst may be older news that markets are only now digesting or repricing. Second, the move could be driven by technical factors such as short-covering, options expiration dynamics, or algorithmic trading in response to chart patterns. Third, a company-specific announcement (earnings, guidance, product launch, or partnership) may have been released but not yet indexed by the news feed at the time of this snapshot. For semiconductor capital equipment companies like AXT, typical catalysts include quarterly earnings beats, new customer wins, or positive industry cycle signals, but without headline confirmation none of these can be claimed here.
No news headlines were found in the last 48 hours, so the 19% jump in Fossil Group stock likely stems from technical factors, delayed news pickup, or market sentiment shifts unrelated to public announcements.
Fossil Group experienced a strong single-day gain of 19.15%, ranking as the 46th biggest mover on NASDAQ, yet no relevant news headlines appear in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect suggests the catalyst was either (1) technical in nature, such as short covering or algorithmic buying pressure, (2) a delayed market reaction to older news that did not yet propagate into the recent feed, or (3) sector-wide or macro sentiment affecting watches and consumer discretionary stocks. Fossil is a mature consumer brand with exposure to smartwatches and fashion accessories, segments that can respond to sentiment shifts around wearables or luxury consumer spending. Without concrete headlines, attribution remains speculative.
The only news released in the past 48 hours is a routine announcement that Gogoro will report Q2 2026 earnings on August 24, which does not explain an 19% intraday gain on August 3rd.
The earnings announcement itself is not a catalyst for a same-day jump; it simply schedules a future disclosure date. The timing mismatch between the news (routine event notification) and the magnitude of the move suggests the 18.97% gain is driven by something not captured in the provided headlines. Possible explanations include a separate corporate announcement, analyst upgrade, short squeeze, broad sector rotation, insider buying rumors, or progress on business deals not yet disclosed publicly. Without additional headlines or structural context about Gogoro's float, leverage, or short position, the root cause remains unclear. The stock is ranked 47 among daily gainers, indicating this is a material market movement that warrants investigation beyond the earnings date announcement.
No news headlines were found in the last 48 hours, so the +18.75% gain likely reflects technical trading, a delayed market reaction to an earlier announcement, or typical volatility in a low-priced rights security.
The absence of recent news makes it difficult to identify a specific catalyst for today's move. TRGSR is a rights offering from a SPAC (TRG Latin America Acquisitions Corp.), a security class known for significant intraday volatility driven by small volumes and speculative positioning. Rights securities are highly sensitive to underlying deal dynamics, extension votes, liquidation risks, and redemption announcements. A gain of this magnitude on a rights instrument could stem from an extension announcement, redemption delay, deal progress update, or simply algorithmic or retail positioning shifts. Without headline support, the move appears driven by technicals or information not yet reflected in the Yahoo Finance feed.
Commercial Vehicle Group reported Q2 2026 revenue of $195.2 million, beating Wall Street expectations with 13.5% year-over-year growth, and raised full-year guidance, driving the 18.66% gain.
The stock's sharp 18.66% rally is directly attributable to the company's Q2 earnings release on August 3, 2026. CVGI posted revenue ahead of consensus estimates at $195.2 million with strong 13.5% YoY growth across all three business segments. While the company reported a negative EPS of $0.25, the adjusted EBITDA of $5.4 million and forward-looking guidance raise signal confidence in operational momentum. The combination of a top-line beat, broad-based segment strength, and upward guidance revision typically catalyzes significant positive repricing in small-cap industrials, particularly vehicle systems suppliers that have limited analyst coverage and smaller float. The timing of the earnings release after market close on August 3 aligns precisely with the stock's inclusion in the day's top gainers.
No news headlines were found in the last 48 hours, so the 18.37% gain likely reflects technical trading, a delayed announcement, or sector-level momentum in the entertainment space, but no specific catalyst can be identified from available data.
The absence of recent news on Yahoo Finance RSS within the last 48 hours means we cannot anchor the move to a concrete event such as earnings, a product launch, or a partnership announcement. Kustom Entertainment is a small-cap stock trading at $1.45, which typically exhibits higher volatility and can move on lower volume or on catalysts that may not immediately surface in mainstream financial news feeds. Possible explanations include a private placement or insider transaction not yet widely reported, short covering or algorithmic accumulation at technical support levels, delayed disclosure of previous announcements, or simply sector rotation into entertainment stocks. Without corroborating headlines or structural insights into the company's capital structure or short interest profile, we cannot distinguish between these scenarios.
Biggest Losers
50No news headlines were found in the last 48 hours, but a 93% single-day collapse in a SPAC suggests either a failed merger announcement, termination of acquisition talks, or a major adverse disclosure.
Global Partner Acquisition Corp II is a blank-check company (SPAC), and a decline of this magnitude with no accompanying news in the provided feed is unusual but not unprecedented. SPACs typically see dramatic moves when merger negotiations conclude, fail, or face regulatory obstacles. Given the extreme severity of the drop and the absence of reported headlines, the most likely scenarios are: a merger deal has been terminated or announced as significantly dilutive to shareholders, the SPAC has been forced to liquidate or wind down, or a major negative legal or regulatory development was disclosed outside the monitored news channels. The timing and magnitude suggest an event material enough to warrant immediate disclosure but perhaps not yet fully propagated through major financial news RSS feeds at the snapshot time.
No headlines were found in the last 48 hours to explain IPCX's 51% plunge, making the precise cause unclear. A blank-check company trading below $5 is vulnerable to liquidity events, redemptions, or deal-related uncertainty.
IPCX is a special purpose acquisition company (SPAC), a structure prone to sudden sharp moves when redemption deadlines approach, merger deals collapse or face delays, or investor confidence shifts. The lack of any news in the headline feed suggests the catalyst may not be widely reported yet, may be structural (a redemption event or scheduled deadline), or may involve delayed disclosure. SPACs trading near NAV-like levels often experience violent swings on leverage effects, warrant mechanics, or binary deal outcomes. Without a specific announcement, the 51% drop likely stems from either a scheduled business combination failure, a redemption window closing, or market-wide repricing of SPAC risk.
No news headlines were available in the last 48 hours, so the driver of this near-50% single-day collapse remains unknown without additional information about earnings, guidance, regulatory action, or other corporate events.
Inno Holdings experienced a catastrophic 49.72% single-day decline on August 3, 2026, yet no news headlines appear in the provided search results from the last 48 hours. This absence of corroborating news does not mean no catalyst occurred, only that it is not captured in the available feed. For a stock to lose half its value in one day typically requires a material negative event: earnings miss with guide-down, product recall or regulatory failure, executive departure, debt covenant breach, accounting restatement, or major contract loss. Without access to company filings, press releases, or trading halts that occurred on August 3, we cannot identify the specific trigger. The timing gap between the snapshot date and the news search window may also mean the announcement occurred after the news fetch cutoff.
No news headlines were found in the last 48 hours, so the 43.52% decline cannot be directly attributed to any announced event. The drop may reflect sector rotation out of solar stocks, delayed negative news, or technical selling.
The absence of recent news headlines makes pinpointing the exact cause difficult. However, a 43.52% single-day drop in a solar energy stock warrants consideration of several common catalysts in this sector. Solar companies are sensitive to changes in renewable energy policy, subsidy announcements, or shifts in government support. Alternatively, the decline could reflect broad sector weakness, disappointing quarterly results announced outside the 48-hour window, analyst downgrades, supply chain disruptions affecting the solar industry, or margin concerns tied to raw material costs. Without corroborating headlines, it is also possible that negative news broke after market close on August 2 but was not yet indexed by the RSS feed at snapshot time. Technical factors such as profit-taking after a prior rally or forced selling by a large shareholder should not be ruled out.
Elong Power announced a US$1.38 million public offering on August 3rd, which likely triggered a 37.89% single-day drop due to dilution concerns and selling pressure from the equity issuance.
The company announced pricing of a public offering of US$1.38 million on the same day as the stock's sharp decline. Public offerings, particularly at small scale relative to market cap, commonly trigger immediate sell-offs because existing shareholders face dilution from newly issued shares. The timing of the announcement coinciding exactly with the largest single-day loss suggests the market reacted negatively to the capital raise. Without details on the offering's terms, share count impact, or use of proceeds, the magnitude of the decline could also reflect broader market skepticism about the company's financial position or growth trajectory if a capital raise was deemed necessary. For a micro-cap energy storage company trading at $0.10, even modest dilution can move the stock significantly.
No news headlines were published in the last 48 hours, so the 37% drop cannot be directly attributed to any identifiable company announcement or market event reported by Yahoo Finance during this period.
Focus Universal (FCUV) experienced a severe single-day decline of 37% with zero news coverage in the prior 48 hours according to the data provided. This disconnect between magnitude and available information suggests either a delayed market reaction to earlier news, a sudden development not yet captured in RSS feeds, or a catalyst external to standard corporate announcements. Micro-cap stocks like FCUV are often susceptible to sector-wide selloffs, technical breakdowns of support levels, short liquidations, or undisclosed corporate events that may take hours to surface publicly. Without identifiable headlines, the true catalyst remains unknown, though the scale of the move warrants investigation into earnings misses, insider transactions, debt concerns, or operational disruptions that may have triggered algorithmic or panic selling.
No news headlines were found in the last 48 hours, so the 34.8% drop cannot be attributed to a specific announced event. The decline likely stems from broad market pressure, technical selling, or unannounced company developments.
The absence of any news in the Yahoo Finance RSS feed over the last two days means we cannot point to a specific catalyst such as earnings, guidance revision, contract loss, or regulatory action. For a stock experiencing a 34.8% single-day decline, typical drivers would include disappointing quarterly results, executive departures, failed product launches, major customer losses, or significant negative research coverage. Without access to those details, we can only note that such a steep move usually reflects either material company-specific news that has not yet propagated to major news aggregators, strong technical selling pressure (perhaps after a resistance break), or delayed market reaction to an earlier announcement. The rank as the seventh biggest loser suggests this is a genuine broad-market shock rather than isolated volatility.
No news headlines appeared in the last 48 hours, so the 30% drop likely stems from technical selling, a delayed press release, or sector-wide volatility affecting this micro-cap stock.
FingerMotion is a micro-cap OTC-adjacent security trading at $0.21, and no recent news is available to explain the sharp 30% single-day decline. For stocks in this price and market-cap range, moves of this magnitude often occur without contemporaneous headlines due to low liquidity, retail trading dynamics, or delayed news dissemination across financial wires. The absence of any headlines in the Yahoo Finance RSS feed over the preceding 48 hours suggests either that no material event occurred or that information spread through channels not captured by this feed. Possible causes, offered as inference rather than fact, include: (1) a technical breakdown or stop-loss cascade on low volume, or (2) an unannounced corporate development—such as a dilutive financing, insider selling, or a regulatory filing—that has not yet been formally reported. Without additional context, the true driver remains unclear.
No news headlines were found in the last 48 hours for GYGY, so the 27% single-day drop likely resulted from an unannounced event such as insider selling, short-squeeze reversal, technical breakdown, or a news release not yet indexed by Yahoo Finance.
The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for the sharp 27% decline. Game Your Game is a small-cap NASDAQ stock, which are typically more volatile and prone to swings driven by retail trading, short covering, or liquidity events. Without earnings, guidance, regulatory, or M&A announcements in the record, the decline could reflect several possibilities: a negative press release or regulatory filing not yet reflected in feeds, profit-taking after a recent rally, or technical selling triggered by a key support level breaking. For micro-cap or gaming-related stocks, sentiment swings and low trading volume can amplify moves on limited catalysts. The ranking as the ninth biggest loser suggests broad-based selling rather than isolated weakness.
No relevant news headlines were found in the last 48 hours, so the 24.66% drop cannot be directly attributed to a disclosed event; the decline may reflect technical selling, delayed market reaction to an earlier announcement, or broader biotech weakness.
The absence of any news headlines in the 48-hour window preceding this significant decline is noteworthy. CalciMedica is a clinical-stage biotech company, and such stocks are sensitive to clinical trial results, regulatory actions, financing updates, and insider transactions, which can drive sharp moves. The stock's rank as the tenth-biggest loser today suggests material selling pressure. Without a headline to anchor the cause, the decline could reflect a delayed market reaction to an announcement made earlier, a private development not yet picked up by major news feeds, technical or sector-wide pressure on smaller biotech names, or short covering or forced liquidation. The biotech sector experienced volatility in this period, which may have contributed.
No news headlines were reported in the last 48 hours, so the 24% drop cannot be directly attributed to a disclosed event. The decline likely reflects either a delayed market reaction to earlier news, a technical or trading-related event, or an undisclosed corporate development.
The absence of recent headlines creates significant uncertainty about the cause of PowerCompute's sharp 24% decline on August 3, 2026. For a stock ranked as the 11th biggest loser of the day, a move of this magnitude typically correlates with material corporate news, earnings misses, guidance cuts, regulatory action, or major contract losses. However, none of these appear in the provided news feed. Possible explanations include a market reaction to news that has not yet propagated to the Yahoo Finance RSS feed, a technical breakdown or short covering event, an internal announcement made directly by the company before press distribution, or the unwinding of a speculative position. Without additional information, the specific catalyst remains unknown.
No news headlines were found in the last 48 hours, so the 23.59% drop cannot be attributed to a specific announced catalyst. The decline likely reflects either a delayed market reaction to an older announcement, technical selling, or sector-wide pressure in metals or small-cap equities.
Without recent news coverage, we cannot identify a specific catalyst for EMAT's sharp decline. This is a small-cap metals and technology company, sectors that are sensitive to commodity prices, market liquidity conditions, and investor risk sentiment. The stock's rank as the 12th biggest loser suggests broader selling pressure rather than an isolated event. Possible explanations include a delayed sell-off from a prior announcement not captured in the last 48 hours, a significant insider sale, margin call pressure on retail holders, or weakness in mining or battery metal prices if EMAT is exposed to those markets. Without access to the company's social media, SEC filings, or broader commodity or sector news from beyond the provided headlines, we cannot narrow this further than educated guesses about typical catalysts for this type of equity.
No news headlines were found in the last 48 hours to explain MIRA's 22.74% drop, making the specific cause unclear without access to intraday announcements or market events.
Despite the significant single-day decline ranking MIRA as the 13th biggest loser on NASDAQ, no recent news headlines are available to point to a concrete catalyst such as earnings disappointment, clinical trial results, FDA action, or guidance revision. For small-cap biotech and pharmaceutical stocks like MIRA trading near $0.61, typical drivers of sharp downward moves include negative clinical data, regulatory setbacks, capital raises at unfavorable terms, insider selling, or shifts in analyst sentiment. The absence of news coverage does not rule out a material announcement that simply has not yet reached major financial wire services, a pre-market or after-hours development, or technical selling driven by technical levels or short covering. Without visibility into intraday news flow or the company's current pipeline status and financial position, the underlying cause remains speculative.
No news headlines were found in the last 48 hours, so the 22.67% decline cannot be directly attributed to a published announcement. The drop likely reflects either technical selling pressure, warrant-specific dynamics, or an untracked market event.
The absence of news in the RSS feed over the past two days makes it impossible to pinpoint a specific catalyst for this steep 22.67% decline in EONR.WT. This is a warrant security, which tends to be more volatile and thinly traded than the underlying stock, amplifying price swings on lower volume. Warrant holders are sensitive to time decay, changes in the underlying asset's volatility, and shifts in implied leverage. Without published headlines, the move could reflect a sharp drop in the underlying EON Resources stock that cascaded into the warrant, a sudden spike in implied volatility that compressed warrant value, or simply technical/liquidity-driven selling in a thinly traded vehicle. It is also possible a material announcement exists but was not picked up by the Yahoo Finance RSS feed during the snapshot window.
No news headlines were found in the last 48 hours, so the 22.38% drop cannot be attributed to a specific announced event. The decline is likely driven by technical selling, market sentiment, or unreported catalysts.
The absence of any news coverage in the last 48 hours is notable given the severity of the move—a 22.38% single-day loss ranking fifteenth among all NASDAQ decliners is substantial. This suggests either that the catalyst was not captured by the Yahoo Finance RSS feed, or that the stock is responding to technical factors such as profit-taking, margin liquidation, or sector rotation. JIADE Limited as a smaller-cap NASDAQ name may also be sensitive to insider transactions, short squeezes unwinding, or rumors that circulate without formal press releases. Without specific headlines linking to earnings, product recalls, litigation, regulatory action, or management changes, the true driver remains opaque. The timing of such a sharp move without visible news justifies skepticism about whether this is normal volatility or an overlooked event.
No news headlines were found in the last 48 hours, so the 22% decline likely stems from technical selling, broader market weakness, or untracked news such as a private company development or analyst downgrade.
Exyn Technologies experienced a sharp 22% single-day drop with zero news coverage in the prior 48 hours according to the search results provided. This disconnect between magnitude and visible catalyst suggests either the move was driven by technical factors, sector rotation, or a news event that did not appear in the Yahoo Finance RSS feed during the specified window. Possible explanations include institutional selling triggered by a prior earnings report or guidance miss that was already public, broader weakness in drone or autonomous systems stocks, short covering reversal, or a material announcement made outside standard news channels. Without confirmed headlines tying to the move, any specific cause remains speculative.
No news was reported in the last 48 hours; the 20% drop in ZIVO is unexplained by available headlines and likely reflects either delayed news, sector pressure, or technical/speculative selling common in small-cap biotech stocks.
The absence of any headlines in the last 48 hours despite a substantial 20% single-day decline suggests the catalyst either occurred before the reporting window, was not picked up by major feeds, or reflects technical selling unconnected to company-specific news. ZIVO is a small-cap biotech firm where price movements are often driven by clinical trial results, FDA decisions, financing announcements, or shifts in sector sentiment toward early-stage life sciences companies. Without confirmatory news, it is reasonable to infer the drop could stem from one of these categories: an announced or leaked development related to pipeline assets, a broader biotech sell-off, or speculative liquidation. The size of the move (17th biggest loser) suggests meaningful volume and conviction, but without evidence we cannot determine whether that reflects informed trading or algorithmic pressure.
Genprex announced a Roche Diagnostics collaboration that initially drove a 3% gain Monday morning, but the stock fell 19.97% by day's close, suggesting either a sharp afternoon reversal, profit-taking after the initial spike, or an undisclosed negative development that overshadowed the news.
The timeline presents an apparent contradiction. Two headlines both dated August 3rd announce the same Roche Diagnostics biomarker validation collaboration, with the first reporting a 3% share gain. However, the closing snapshot shows a 19.97% loss, ranking GNPX as the 18th biggest loser of the day. This inversion could reflect several scenarios. First, the positive news may have triggered a classic sell-the-news response after initial enthusiasm faded. Second, additional negative news not captured in the provided headlines may have emerged later in the trading day. Third, short covering or margin calls could have accelerated the decline. Without additional headlines or intraday data, the exact mechanism remains unclear. For clinical-stage biotech stocks, investor sentiment often swings sharply on partnership announcements and cash runway concerns.
FFAI fell 19.53% despite the company announcing record robotics sales and launching a USA manufacturing program. The disconnect between positive news and sharp decline suggests broader market or sector headwinds rather than company-specific negative catalysts.
The news released on August 3 portrays operational progress: record monthly robotics sales, a new "Built in USA" acceleration program, and a partner recruitment conference preview. These are ostensibly constructive announcements for investor relations. However, the 19.53% drop indicates the market either disbelieved the claims, viewed them as insufficient to justify valuation, or was driven by factors unrelated to the headline. Faraday Future has a history of ambitious announcements and delayed execution. Alternatively, this could reflect broader EV or speculative tech sector weakness on the snapshot date, sector rotation, short covering reversals, or a previously announced event (earnings, dilution, or guidance) that was already baked into expectations and now repriced lower as reality checks against prior hype.
La Rosa Holdings reported Q1 2026 earnings showing strong gross profit and revenue growth, but the stock fell 18.91% anyway, suggesting investors either expected better results, are concerned about profitability despite operational improvements, or are reacting to forward guidance or balance shee…
The earnings release headline highlights genuinely positive metrics: gross profit up 29.6% year-over-year to $2.0 million and commercial real estate brokerage revenue soaring 379.3% to $273 thousand, with a 46.5% improvement in loss from operations. These are objectively favorable comparisons. However, the headline is truncated and does not disclose absolute operating loss, net loss, earnings guidance, or other material details that could explain a steep single-day decline. A micro-cap stock trading at $0.81 is sensitive to sentiment shifts; investors may have interpreted the incomplete earnings as missing on bottom-line profitability, may have seen guidance that tempered enthusiasm, or may be pricing in execution risk or dilution concerns not visible in the abbreviated headline. Alternatively, the sell-off could reflect profit-taking on momentum or a broader micro-cap selloff unrelated to this specific announcement.
Edible Garden announced a multi-year private label supply agreement extending through 2028 with a major Midwest retailer, yet the stock fell 18.8% the same day, suggesting the market viewed the news as insufficient or priced in worse-than-expected terms despite the positive headline framing.
The announced news is materially positive on its surface: a multi-year contract extension with a major big-box retailer strengthens retail distribution and provides revenue visibility through 2028. However, the stock's sharp 18.8% decline on the day of announcement indicates the market either (a) found the deal terms, pricing, or margin implications disappointing relative to expectations, (b) interpreted the announcement as confirmation of slowing growth or competitive pressure that required this partnership to be re-emphasized, or (c) reacted to missing information such as contract value, volume commitments, or profitability metrics that weren't disclosed in the headline summaries provided. Without access to the full press release or earnings context, the disconnect between positive framing and negative price action suggests the street's initial read differed materially from the company's narrative.
No news headlines were found in the last 48 hours, so the 18.52% drop likely reflects technical selling, warrant-specific pricing dynamics, or unannounced company developments that have not yet reached financial media.
NVA.WT is a warrant security, which trades with structural leverage and time decay relative to its underlying equity. The absence of any news in the provided 48-hour window means the drop cannot be tied to a specific company announcement, earnings report, regulatory action, or macro catalyst that was publicly disclosed. Warrant prices are sensitive to implied volatility changes, underlying stock weakness, and shifts in the probability that the warrant will finish in-the-money before expiration. The sharp one-day loss could reflect: (1) a decline in the underlying NVA common stock not shown in these headlines, (2) a sudden contraction in implied volatility, (3) warrant-specific selling unrelated to fundamental news, or (4) an undisclosed announcement that has not yet propagated to major financial news feeds. Without access to contemporaneous data on NVA common stock performance or warrant-specific activity, attributing this move to a specific cause is not possible.
No news headlines were found in the last 48 hours to explain Bio-key's 17.93% drop, so the cause remains unclear; the decline could stem from a delayed announcement, technical selling, sector weakness, or market rumors not yet indexed by major news feeds.
Bio-key International experienced a significant single-day loss of nearly 18% with no corresponding news in the 48-hour window provided. This disconnect between magnitude and visible catalyst is common in smaller-cap stocks like BKYI, which tend to be sensitive to unannounced earnings revisions, insider transactions, short-seller reports, or shifts in biometric authentication market sentiment. Given the absence of any headline, plausible explanations include a delayed earnings announcement or guidance miss that hasn't yet propagated through major news services, sector-specific headwinds affecting identity verification or fintech stocks, or technical selling triggered by a breach of a key technical level. Without corroborating news, the true driver cannot be confidently identified.
No news headlines were found in the last 48 hours, so the 17.58% drop cannot be attributed to a reported event; the cause likely involves technical selling, delayed news not yet indexed, or market-wide pressure on small-cap stocks.
Yahoo Finance returned no headlines for TWG in the 48 hours preceding this snapshot, which is a significant limitation. A decline of this magnitude in a stock typically correlates with earnings misses, guidance cuts, insider selling, litigation, regulatory action, or adverse sector trends. Without news to ground the analysis, we can only infer categories of potential causes. Small-cap stocks like TWG are often illiquid and subject to technical selling or momentum reversal. It is also possible that relevant news exists but has not yet propagated to Yahoo Finance's RSS feed, or that the move reflects delayed market reaction to older developments. Without access to real-time market commentary, filings, or insider activity on the snapshot date itself, attribution remains speculative.
WeTouch announced a $38.8 million insider share subscription with a 12-month lock-up on the same day the stock fell 16.67%, suggesting investor concern over dilution and insider timing despite the stated long-term commitment signal.
The headline announces that founders, directors, and management are investing approximately $38.8 million in new shares at a "premium price" with a 12-month lock-up period. While insider investment is typically framed as a positive signal of confidence, the market's sharp 16.67% decline on the same day suggests investors interpreted this differently. Possible explanations include: the subscription was at a price materially above the current trading level, triggering dilution concerns; the market viewed the lock-up as an indirect admission that insiders expect near-term weakness; or the announcement coincided with other negative sentiment not captured in the headline excerpt. Without full details on the subscription price relative to current market price and broader context, the precise driver remains partially unclear, though the timing correlation is direct.
Nexera announced a letter of intent for exclusive distribution rights to a darknet intelligence platform on August 3rd, but the market reacted with a 14.93% sell-off, suggesting investor skepticism about the deal's value or execution risk rather than enthusiasm for the partnership.
The headlines describe a positive corporate development—a letter of intent granting Nexera exclusive worldwide rights to market and distribute Nebo Holdings' Preempt OSINT cybersecurity platform to data center operators. On the surface, this is a revenue-generating partnership. However, the stock fell sharply the same day the news broke, which is counterintuitive. Possible explanations include: (1) market concern about the terms or non-binding nature of an LOI (letter of intent is preliminary and non-exclusive to Nexera's execution), (2) questions about Nexera's capability to effectively distribute a specialized cybersecurity product, (3) investor disappointment that the deal was not larger or more concrete (such as a binding contract with revenue commitments), or (4) pre-existing negative sentiment or technical selling that coincided with the announcement. Without details on valuation impact, exclusivity scope, or revenue guidance, the sell-off reason remains unclear.
Sportradar dropped 14.87% after reporting Q2 earnings that missed analyst expectations on both earnings and revenue, combined with a disappointing full-year guidance reduction despite 19% revenue growth.
The headlines establish a clear earnings miss narrative. While Sportradar reported strong headline revenue growth of 19% to €378 million, the company reported a net loss of €4 million for the quarter and delivered an earnings surprise of -116.67% (essentially reporting a loss when profit was expected). More critically, management lowered its full-year outlook, which typically triggers sell-offs regardless of near-term revenue strength. The company faced headwinds from US market moderation that apparently exceeded investor expectations. The combination of the earnings miss, revenue that came in slightly below estimates at -0.39% surprise, and reduced forward guidance created a three-part disappointment that justified the 16% intraday decline. This is a classic case where top-line growth masks underlying profitability and margin concerns, prompting investors to reprice the stock downward.
No news headlines were published in the last 48 hours for SBXD.WT, so the 14.47% decline cannot be directly attributed to a specific announced event. Warrant-class securities are highly volatile and sensitive to moves in their underlying stock or shifts in implied volatility.
The absence of recent headlines means we cannot point to earnings, guidance, regulatory action, or other discrete news events as the cause of today's drop. SBXD.WT is a warrant issued by SilverBox Corp IV, a special purpose acquisition company, making it a leveraged derivative security. Warrants are inherently volatile and respond sharply to small percentage moves in the underlying stock price, changes in time decay as expiration approaches, or shifts in volatility expectations. Without news context, the most likely causes are technical selling, rebalancing, or a decline in the underlying SPAC's share price. Warrant holders may also be exiting positions ahead of near-term expiration or in response to deteriorating merger prospects, but this cannot be confirmed from the available evidence.
No news headlines were available in the last 48 hours to explain ATXG's 14.16% drop, so the cause remains unclear from public information.
ATXG dropped 14.16% on August 3rd, 2026, but no recent news headlines were found in the Yahoo Finance RSS feed covering the past 48 hours. Without a specific catalyst identified in available news, the decline could stem from several typical categories: broad market weakness affecting small-cap equities, sector rotation out of the company's industry, negative sentiment from an earnings miss or delayed earnings announcement, insider selling or stock offering activity, technical selling triggered by a broken support level, or loss of investor confidence due to unannounced operational challenges. Small-cap stocks like ATXG are often more volatile and responsive to intraday sentiment shifts, after-hours developments, or trading halts that may not immediately appear in headline feeds. Without confirmed information, attribution remains speculative.
No news headlines were found in the last 48 hours, so the 13.3% decline likely reflects either technical selling pressure on a low-price warrant or delayed market reaction to an untracked event.
Viking Acquisition Corp. I warrants (VACI.WT) experienced a sharp single-day decline with zero news coverage in the provided feed. Warrants are derivatives sensitive to both underlying SPAC dynamics and time decay, and they often exhibit exaggerated price swings relative to the common stock. Without recent headlines, the move could stem from several warrant-specific factors: deteriorating merger prospects or timelines affecting the underlying SPAC, time decay as the warrant approaches expiration or key decision dates, shifts in implied volatility, or redemption pressure from SPAC common stockholders. It is also possible that relevant news exists but was not captured in this particular feed. The lack of any identified catalyst makes it difficult to distinguish between a fundamental shift in deal sentiment and a purely technical or liquidity-driven pullback common to low-priced warrants.
No news headlines were found in the last 48 hours, so the 13.11% drop cannot be tied to a specific announced catalyst. The decline likely reflects sector sentiment, technical selling, or delayed market reaction to an earlier event.
Without recent news coverage, we cannot identify a specific catalyst for Nocera's 13.11% single-day drop. Nocera is a small-cap technology company, and stocks in this category are often sensitive to broad market conditions, sector rotation, or technical levels even without fresh headlines. The absence of news does not rule out an internal catalyst—such as an earnings miss, insider selling, or a delayed press release not yet picked up by Yahoo Finance RSS—or external factors like a sell-off in similar stocks or profit-taking after a prior run. For a company trading near $1.76, liquidity constraints can also amplify single-day moves on moderate volume. Without access to intraday trading data, social media sentiment, or real-time earnings/guidance updates, we cannot pinpoint the driver with confidence.
No news headlines were found in the last 48 hours, so the 12.93% decline in this warrant cannot be attributed to a specific announced event; warrant prices are highly sensitive to underlying stock moves and implied volatility, making intraday swings common without news.
The absence of news in the last 48 hours means this move was likely driven by technical factors or indirect developments not captured in major news feeds. Warrants are leverage instruments whose value depends on the underlying common stock's price, implied volatility, time decay, and moneyness. A 12.93% drop could reflect a decline in NWTN's common stock price, a drop in implied volatility, or simple time decay as the warrant approaches expiration or loses intrinsic value. Warrant holders are also more prone to exit positions on liquidity concerns or margin pressures. Without headline evidence of a catalyst affecting NWTN Inc. itself, the most likely explanations are either a move in the underlying equity not yet reflected in major news services, or pure mechanical warrant repricing.
No news headlines were found in the last 48 hours, so the 12.89% drop on August 3, 2026 cannot be directly attributed to a specific announcement. The decline likely reflects broader biotech sector weakness, sector-specific sentiment, or undisclosed company developments.
The absence of any recent news headlines in the provided feed makes it impossible to pinpoint a concrete catalyst for SHPH's sharp decline. Shuttle Pharmaceuticals is a clinical-stage or early commercial-stage biopharmaceutical company, and stocks in this category are typically sensitive to clinical trial outcomes, regulatory decisions, financing events, or shifts in therapeutic area sentiment. Given that the stock ranks 33rd among the day's biggest losers, it is reasonable to infer that either a sector-wide sell-off affected smaller biotech names disproportionately, a company-specific development occurred but was not captured in the Yahoo Finance RSS feed within the 48-hour window, or market dynamics such as options expiration or technical selling pressure contributed. Without confirmed news, these remain hypotheses rather than established causes.
No news headlines were published about NXTT in the last 48 hours, so the 12.88% decline likely stems from technical selling, sector rotation, or an unannounced development not yet reflected in financial media.
The absence of any recent news makes it impossible to identify a specific catalyst for the decline. NXTT is a micro-cap stock trading at $0.43, a category typically more sensitive to retail flows, liquidity events, and sentiment shifts than to fundamental news. The drop could reflect several common patterns in this space: a shift in sector momentum if NXTT operates in technology or biotech, profit-taking after a prior run-up, options expiration effects, or a delayed market reaction to an announcement that hasn't yet surfaced in major news feeds. Without headline evidence, we cannot determine whether this is technical retracement, legitimate bad news that hasn't propagated yet, or simply low-volume trading dynamics typical of penny stocks.
PFAI dropped 12.60% on August 3, 2026, but the only news available is a routine independent director appointment announcement, which does not explain a move of this magnitude and is typically neutral or positive for governance.
The headline on file announces the appointment of Martin Ngai Lam Cheung as an independent director, effective immediately. Board appointments, especially independent director additions, are generally neutral to slightly positive signals for corporate governance. This announcement does not contain earnings misses, revenue warnings, regulatory setbacks, contract losses, or other substantive operational or financial news that would trigger a 12.60% single-day decline. The timing of the announcement (posted after market close at 20:35 UTC) also suggests it was released after the bulk of trading occurred. The gap between the neutral nature of the news and the magnitude of the drop indicates that either (1) material news was released through other channels not captured in this RSS feed, (2) the stock reacted to broader market or sector headwinds unrelated to the director appointment, or (3) the decline reflects accumulating concerns about the company's fundamentals that the single available headline does not address.
GameStop announced a $1.4 billion debt-for-equity swap on August 3, 2026, converting notes into shares without using cash, which triggered a 12-13% sell-off as investors feared dilution despite the financial benefit of reducing debt.
The headlines establish that GameStop exchanged approximately $1.4 billion in convertible notes (roughly $400 million due 2030 and $1 billion due 2032) for Class A shares, a move that eliminates debt without consuming cash. The stock fell 6-13% throughout the trading day as this news spread. The mechanism is straightforward: while debt reduction strengthens the balance sheet, converting debt to equity increases share count and dilutes existing shareholders, particularly problematic for a stock that had only recovered to breakeven for the year. The timing of a 35-day pricing window in September suggests the final share impact remains uncertain, which likely amplified sell pressure from investors concerned about unknown dilution levels. This is a classic debt refinancing trade-off where creditors gain equity stakes while shareholders face dilution.
No news headlines were found in the last 48 hours to explain COPR.WT's 12.22% decline, so the cause remains unclear without additional market context or company-specific information.
The absence of any recent news in the Yahoo Finance RSS feed over the past two days makes it difficult to pinpoint a specific catalyst for this sharp move. COPR.WT is a warrant, which are leveraged instruments that can exhibit outsized volatility relative to their underlying security. Warrant prices are sensitive to changes in the underlying stock's price, implied volatility, time decay, and interest rates. Without knowing the structure of this particular warrant or recent performance of its underlying equity, reasonable hypotheses include: first, a sharp decline in the underlying security that warrant holders are reacting to with amplified selling; second, technical liquidation or forced selling within a warrant trading position; or third, deterioration in implied volatility that reduces warrant valuation. The lack of news does not rule out that the move was prompted by a non-public rumor, technical breakdown, or broad sector rotation affecting the underlying company.
No news headlines were published in the last 48 hours for SGLY, so the 12.18% drop on August 3, 2026 cannot be attributed to a specific announced catalyst; the move likely reflects technical selling, sector rotation, or undisclosed company developments.
The absence of any Yahoo Finance news in the 48-hour window preceding this significant one-day loss makes it impossible to identify a concrete announced trigger. SGLY is a micro-cap technology stock, and such securities are often more susceptible to momentum shifts, algorithmic selling, profit-taking after rallies, or shifts in risk appetite across small-cap growth names. It is also possible that negative information circulated through non-traditional channels (social media, message boards, or insider conversations) before reaching mainstream financial news wires, or that the stock experienced a technical breakdown following resistance. Without headline evidence, we are limited to observing that the drop falls into a typical pattern for illiquid, speculative names during periods of market stress or momentum unwinding.
No news headlines appeared in the last 48 hours, so the 11.76% decline on UAC.WT cannot be attributed to a specific reported event. The drop may reflect broader warrant market weakness, underlying asset volatility, or technical selling.
The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for UAC.WT's decline. This security is a warrant, a leveraged derivative instrument that amplifies price moves and is typically more volatile than the underlying stock. Warrant prices are sensitive to multiple factors beyond company fundamentals, including changes in implied volatility, time decay as expiration approaches, shifts in the underlying asset's price, and broader liquidity conditions in the warrant market. Without information about the underlying security's name or performance on this date, or details about the warrant's strike and expiration, we cannot determine whether the decline reflects deterioration in the underlying company, technical warrant-market dynamics, or exogenous market conditions. The drop could also reflect algorithmic selling or a delayed market reaction to older news not captured in the 48-hour window.
No headlines were published in the last 48 hours for SNAL, so the 11.7% drop cannot be traced to a specific news event. The decline likely reflects either technical selling pressure, sector rotation, or a delayed market reaction to an earlier untracked announcement.
The absence of any Yahoo Finance headlines in the past two days makes it difficult to identify a concrete catalyst for SNAL's sharp 11.7% decline on August 3, 2026. For a stock ranked as the 40th biggest loser of the day, this is a material move that typically warrants news coverage or at least identifiable market chatter. Possible explanations include: first, technical or algorithmic selling triggered by a broken support level or chart pattern, common in lower-priced equities with lighter liquidity; second, broad sector weakness in biotech, healthcare, or technology that has pulled the stock down without company-specific news; third, a delayed reaction to earlier news that may have circulated through non-RSS channels or social media before formal wire pickup. Without direct evidence, any explanation remains speculative.
No news headlines were found in the last 48 hours, so the 11.69% decline cannot be directly attributed to any announced event; the drop likely reflects either a delayed market reaction, technical selling pressure, or untracked developments.
The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to connect DCX's sharp decline to a specific catalyst. Given that DCX trades on NASDAQ at a sub-$1 price point and ranks as the 41st biggest loser of the day, several categories of driver are plausible: (1) technical selling or stop-loss triggers common in penny stocks following a prior run-up, (2) a delayed market reaction to an earnings miss, filing, or executive event that occurred just outside the 48-hour window or was announced through channels not captured by the RSS feed, or (3) sector-wide weakness or a company-specific rumor not yet reflected in major news aggregators. Without concrete information, attribution remains speculative.
Powerus announced a major $90 million U.S. Air Force contract, but as the acquirer in a pending merger with PUSA, this win may signal the deal's value is shifting or raising questions about integration risk, sparking a sharp sell-off in the target stock.
The headlines confirm that Powerus—PUSA's proposed merger partner—secured a substantial $90 million Air Force contract through mid-2028. This is objectively positive news for Powerus itself. However, PUSA fell 11.67%, suggesting investors are reacting negatively to this development in the context of the merger. Possible explanations include: (1) concerns that Powerus's large new contract obligations increase execution risk and integration complexity post-merger, potentially diluting synergies; (2) fear that Powerus will prioritize fulfilling the Air Force contract over merger integration, delaying value realization for PUSA shareholders; (3) market reassessment of deal economics, where a now-busier Powerus may renegotiate terms or face valuation pressure. Without the actual merger agreement terms or analyst commentary, we cannot rule out that the headline is simply incomplete coverage and other news drove the move.
No news headlines were found in the last 48 hours, so the 11.64% drop likely reflects either a delayed market reaction to an earlier announcement, technical selling pressure, or sector-wide weakness in biotech. The absence of recent catalogs makes the cause unclear.
Fortress Biotech is a clinical-stage biopharmaceutical company, and these stocks are particularly sensitive to clinical trial readouts, regulatory decisions, financing announcements, and broader biotech sector sentiment. The lack of news in the last 48 hours suggests either a lag between an event and its market impact, or that the decline was driven by technical factors such as profit-taking after a recent run, options expiration effects, or selling pressure unrelated to company-specific news. Biotech stocks with smaller market caps and pipeline-dependent valuations can also be subject to intraday volatility and liquidity-driven moves. Without a specific catalyst in the headlines, the driver remains speculative.
No news headlines were found in the last 48 hours to explain NDRA's 11.63% drop, so the cause remains unclear without additional information.
ENDRA Life Sciences is a small-cap medical technology company, and the absence of any news in the last 48 hours makes it difficult to pinpoint the catalyst for this significant single-day decline. For microcap biotech or medtech firms like NDRA, sharp moves without accompanying headlines can result from several typical categories: delayed announcements or press releases that haven't yet propagated to major news feeds, technical selling or momentum-driven declines following a prior run-up, insider transactions or SEC filings released after market hours, sector-wide weakness in small-cap healthcare, or negative commentary on social media or niche investor forums that hasn't reached mainstream outlets. Without access to real-time trading data, insider filings, or company press releases issued directly, it is impossible to determine which mechanism drove today's move.
No news headlines were found in the last 48 hours, so the 11.54% decline in Ribbon Acquisition Corp Rights cannot be directly attributed to any announced event; the drop likely reflects typical illiquidity and volatility in SPAC rights securities.
The absence of recent news headlines means we cannot tie this move to a specific catalyst such as earnings, regulatory action, or M&A developments. Ribbon Acquisition Corp Rights are a low-liquidity, low-priced security typically held by investors betting on the underlying SPAC's eventual merger or liquidation. Such instruments experience outsized percentage swings on modest volume shifts, and their prices often track sentiment around the parent SPAC's prospects, redemption risk, or management changes. The decline of 11.54% could reflect technical selling, a rotation out of SPAC-adjacent positions, expiring redemption deadlines, or simply a quiet day with thin trading on a micro-cap security. Without headline evidence, the most likely explanation is structural illiquidity rather than company-specific news.
No news headlines were found in the last 48 hours to explain HHS's 11.26% drop, so the cause remains unclear without additional context.
Harte-Hanks Inc experienced a sharp one-day decline of 11.26% with no corresponding news headlines in the prior 48 hours according to the available sources. This disconnect suggests either that relevant news broke outside the monitored feeds, or that the move was driven by technical factors, sector rotation, or broader market conditions not captured in the headline summary. For a micro-cap stock trading near $2, possible explanations include delayed earnings releases or guidance warnings, short covering reversals, insider selling, or contagion from sector-wide or market-wide volatility. Without substantive structural insights into HHS's capital structure or recent trading dynamics, it is not possible to narrow the cause further.
No news headlines were found in the last 48 hours to explain the 11.23% drop in FTFT, suggesting the decline may be driven by technical selling, sector rotation, or undisclosed company developments.
The absence of any recent news headlines in the provided data makes it impossible to identify a specific catalyst for the 11.23% decline. For a micro-cap stock like Future FinTech trading near $0.91, price movements of this magnitude are common and can be triggered by several factors unrelated to major announcements. The most likely explanations include profit-taking or forced liquidations by retail holders, sector-wide weakness in fintech equities, short-seller activity or coordinated selling, or investor concerns about dilution or insider transactions not yet broadly reported. Without access to intraday trading data, option positioning, or insider activity logs, we cannot distinguish between these hypotheses. The stock's position as the 47th biggest loser suggests it was part of a broader market rotation rather than an isolated disaster specific to the company.
No news headlines were found in the last 48 hours, so the 11.21% decline cannot be tied to a specific announced event. The drop may reflect broader market conditions, technical selling, or undisclosed company developments.
The absence of recent news headlines makes it impossible to identify a concrete catalyst for today's 11.21% decline in LNKS. For a micro-cap or thinly traded stock like this (trading at $0.95), price moves are often driven by factors beyond major announcements: technical selling following a previous rally, changes in liquidity or short interest, sector-wide rotation, or delayed disclosure of earnings or corporate events that have not yet reached news feeds. Without access to real-time trading data, social media discussion, insider activity, or company filings from the last 48 hours, the specific driver remains unknown. The stock's position as the 48th biggest loser suggests this was not an isolated glitch but rather a meaningful selloff worthy of market attention.
TG Therapeutics missed Q2 earnings estimates by a wide margin despite raising full-year revenue guidance on strong Briumvi sales, signaling that operational profitability lags revenue growth expectations and triggering a sell-off despite positive commercial momentum.
TG Therapeutics reported Q2 2026 revenue of $240 million, beating expectations by 4.08%, and raised full-year 2026 guidance to approximately $950 million from $925 million on record new patient additions to Briumvi, its multiple sclerosis treatment. However, the company missed earnings per share estimates by 87.81%, a substantial shortfall. The earnings miss appears to have outweighed the positive revenue guidance raise in investor sentiment. This divergence suggests the market is penalizing the company for inability to convert growing sales into proportional bottom-line profit, possibly reflecting higher operating costs, increased R&D spending, or margin pressures as the company scales. The CEO's statement that Briumvi is on track to become a $1 billion US drug was insufficient to offset the EPS disappointment, indicating investors may be skeptical of near-term profitability improvement despite topline acceleration.
No news headlines appeared in the past 48 hours to explain TGE.WT's 11.11% decline on August 3, 2026, so the driver was likely technical selling, broader market weakness, or an undetected announcement.
The absence of any reported headlines in the last 48 hours makes it impossible to pinpoint a fundamental catalyst for this stock's move into the top 50 losers. TGE.WT trades at a low price point of $0.16, which typically indicates either a penny stock or a warrant with limited liquidity. Low-priced securities are prone to sharp moves on modest volume, technical breakdowns, or gap downs following after-hours news that may not yet be reflected in RSS feeds. The stock could have reacted to a broader sector decline, margin pressure, or internally driven liquidation. Without access to real-time Level 2 data, after-hours statements, SEC filings, or social media discussion, no reasonable inference can be made about the specific event.